Cortrosyn .25 mg/mL

Cortrosyn .25 mg/mL is a lyophilized powder for solution, used for diagnostic purposes in evaluating adrenal function. This cosyntropin injection is manufactured by Amphastar Pharmaceuticals, Inc. in the USA.

Cortrosyn .25 mg/mL is primarily used to diagnose adrenal insufficiency. It stimulates the adrenal glands to produce cortisol, helping healthcare providers assess adrenal function. This cosyntropin injection is often used in medical settings to determine if the adrenal glands are working properly. What is Cortrosyn used for? It aids in diagnosing conditions related to adrenal gland dysfunction.

When administered, Cortrosyn .25 mg/mL stimulates the adrenal glands to produce cortisol. This can help identify if the adrenal glands are responding adequately to stimulation. Common effects may include temporary increases in cortisol levels, which are monitored by healthcare professionals during diagnostic procedures.

Cortrosyn .25 mg/mL should be handled with care and administered by healthcare professionals. It is important to follow proper storage and preparation guidelines to ensure the integrity of the lyophilized powder. Always consult a healthcare provider before use to discuss potential risks and benefits.

Cortrosyn .25 mg/mL may interact with other medications that affect adrenal function or cortisol levels. It is important to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain supplements may also influence the effects of this cosyntropin injection.